Ojjaara 81864-0103
Generic: Momelotinib
Product NDC
81864-0103- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 15, 2023
- Listing Expires
- December 31, 2027
- Application
- NDA216873
Need to source Ojjaara? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Momelotinib Dihydrochloride Monohydrate | 100 mg/1 |
Drug Class
Breast Cancer Resistance Protein Inhibitors [MoA]Kinase Inhibitor [EPC]Kinase Inhibitors [MoA]
Packaging Options(1)
30 TABLET in 1 BOTTLE (81864-103-30)